Key result
Statin use in older persons with type 2 diabetes was associated with a 50% lower risk of cardiovascular mortality (95% CI 8% to 72% lower) compared to non-use.
Why the study?
Does statin medication reduce cardiovascular and all-cause mortality in older persons with type 2 diabetes?
Cohort (n=5,152)
No
Does statin medication reduce cardiovascular and all-cause mortality in older persons with type 2 diabetes?
Relative Risk: 0.5 (95% CI 0.28–0.92)
Statin use in older adults with type 2 diabetes is associated with significantly lower cardiovascular and all-cause mortality, comparable to the risk in the general population without diabetes.
No takes yet. Share an insight, caveat, or question.
Statin use was associated with lower mortality in older diabetic adults; leaves open whether RCT benefits extend to routine geriatric care.
Ólafsdóttir et al. (2011) conducted a cohort in Type 2 diabetes (n=5,152). Statin medication vs. No statin use was evaluated on Cardiovascular mortality in persons with diabetes (RR 0.50, 95% CI 0.28-0.92). Statin use in older persons with type 2 diabetes was associated with a 50% lower risk of cardiovascular mortality (95% CI 8% to 72% lower) compared to non-use.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: